Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

NCT01565889 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
HIV

Interventions

DRUG: SOF
DRUG: EFV/FTC/TDF
DRUG: EFV
DRUG: ZDV/3TC
DRUG: ATV
DRUG: Ritonavir
DRUG: FTC/TDF
DRUG: DRV
DRUG: RAL
DRUG: PEG
DRUG: RBV

Sponsor

Gilead Sciences